These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38871846)

  • 21. AI-based CT Body Composition Identifies Myosteatosis as Key Mortality Predictor in Asymptomatic Adults.
    Nachit M; Horsmans Y; Summers RM; Leclercq IA; Pickhardt PJ
    Radiology; 2023 Jun; 307(5):e222008. PubMed ID: 37191484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic Value of Acute-On-Chronic Liver Failure (ACLF) Score in Critically Ill Patients with Cirrhosis and ACLF.
    Lin X; Huang X; Wang L; Feng S; Chen X; Cai W; Huang Z
    Med Sci Monit; 2020 Sep; 26():e926574. PubMed ID: 32978936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of sarcopenia and myosteatosis on postoperative outcomes and 5-year survival in curatively operated colorectal cancer patients - A retrospective register study.
    Aro R; Mäkäräinen-Uhlbäck E; Ämmälä N; Rautio T; Ohtonen P; Saarnio J; Meriläinen S
    Eur J Surg Oncol; 2020 Sep; 46(9):1656-1662. PubMed ID: 32224072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver failure determines the outcome in patients of acute-on-chronic liver failure (ACLF): comparison of APASL ACLF research consortium (AARC) and CLIF-SOFA models.
    Choudhury A; Jindal A; Maiwall R; Sharma MK; Sharma BC; Pamecha V; Mahtab M; Rahman S; Chawla YK; Taneja S; Tan SS; Devarbhavi H; Duan Z; Yu C; Ning Q; Jia JD; Amarapurkar D; Eapen CE; Goel A; Hamid SS; Butt AS; Jafri W; Kim DJ; Ghazinian H; Lee GH; Sood A; Lesmana LA; Abbas Z; Shiha G; Payawal DA; Dokmeci AK; Sollano JD; Carpio G; Lau GK; Karim F; Rao PN; Moreau R; Jain P; Bhatia P; Kumar G; Sarin SK;
    Hepatol Int; 2017 Sep; 11(5):461-471. PubMed ID: 28856540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversibility of acute-on-chronic liver failure syndrome in hepatitis B virus-infected patients with and without prior decompensation.
    Wang H; Tong J; Xu X; Chen J; Mu X; Zhai X; Liu Z; Chen J; Liu X; Su H; Hu J
    J Viral Hepat; 2022 Oct; 29(10):890-898. PubMed ID: 35793410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Obesity is Associated with Longer Survival Independent of Sarcopenia and Myosteatosis in Metastatic and/or Castrate-Resistant Prostate Cancer.
    Xu MC; Huelster HL; Hatcher JB; Avulova S; Stocks BT; Glaser ZA; Moses KA; Silver HJ
    J Urol; 2021 Mar; 205(3):800-805. PubMed ID: 33080148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma.
    Rollins KE; Tewari N; Ackner A; Awwad A; Madhusudan S; Macdonald IA; Fearon KC; Lobo DN
    Clin Nutr; 2016 Oct; 35(5):1103-9. PubMed ID: 26411749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different computed tomography parameters for defining myosteatosis in patients with advanced non-small cell lung cancer.
    Zhang W; Tang J; Tang H; Xie L; Wang J; Wu J; Yang M
    Clin Nutr; 2023 Dec; 42(12):2414-2421. PubMed ID: 37871482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How to identify the need for liver transplantation in pediatric acute-on-chronic liver failure?
    Lal BB; Sood V; Khanna R; Alam S
    Hepatol Int; 2018 Nov; 12(6):552-559. PubMed ID: 30341639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic Liver Failure-Sequential Organ Failure Assessment is better than the Asia-Pacific Association for the Study of Liver criteria for defining acute-on-chronic liver failure and predicting outcome.
    Dhiman RK; Agrawal S; Gupta T; Duseja A; Chawla Y
    World J Gastroenterol; 2014 Oct; 20(40):14934-41. PubMed ID: 25356054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deep learning-based assessment of CT markers of sarcopenia and myosteatosis for outcome assessment in patients with advanced pancreatic cancer after high-intensity focused ultrasound treatment.
    Nowak S; Kloth C; Theis M; Marinova M; Attenberger UI; Sprinkart AM; Luetkens JA
    Eur Radiol; 2024 Jan; 34(1):279-286. PubMed ID: 37572195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low subcutaneous adipose tissue and myosteatosis are prognostic factors after allogeneic hematopoietic stem cell transplantation.
    Barajas Ordonez F; Zeller Y; Wolleschak D; Hinnerichs M; Rodríguez-Feria P; Mougiakakos D; Aghayev A; Kardas H; Mikusko M; Borggrefe J; Surov A
    Clin Nutr ESPEN; 2024 Jun; 61():274-280. PubMed ID: 38777443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cystatin C and Sarcopenia Predict Acute on Chronic Liver Failure Development and Mortality in Patients on the Liver Transplant Waiting List.
    Mauro E; Crespo G; Martinez-Garmendia A; Gutierrez-Acevedo MN; Diaz JM; Saidman J; Bermudez C; Ortiz-Patron J; Garcia-Olveira L; Zalazar F; Narvaez A; Spina JC; Orta R; Savluk L; Piano S; Marciano S; Gadano A
    Transplantation; 2020 Jul; 104(7):e188-e198. PubMed ID: 32150034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transplantation for EASL-CLIF and APASL acute-on-chronic liver failure (ACLF) patients: The
    Xia L; Qiao ZY; Zhang ZJ; Lv ZC; Tong H; Tong Y; Wu HX; Chen XS; Sun HY; Zhang JJ; Thasler WE; Feng H; Xia Q
    EClinicalMedicine; 2022 Jul; 49():101476. PubMed ID: 35747194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative accuracy of prognostic models for short-term mortality in acute-on-chronic liver failure patients: CAP-ACLF.
    Verma N; Dhiman RK; Singh V; Duseja A; Taneja S; Choudhury A; Sharma MK; Eapen CE; Devarbhavi H; Al Mahtab M; Shukla A; Hamid SS; Jafri W; Butt AS; Ning Q; Chen T; Tan SS; Lesmana LA; Lesmana CRA; Sahu MK; Hu J; Lee GH; Sood A; Midha V; Goyal O; Ghazinian H; Kim DJ; Treeprasertsuk S; Mohan Prasad VG; Dokmeci AK; Sollano JD; Shah S; Payawal DA; Rao PN; Kulkarni A; Lau GK; Duan Z; Chen Y; Yokosuka O; Abbas Z; Karim F; Chowdhury D; Prasad AS; Sarin SK;
    Hepatol Int; 2021 Jun; 15(3):753-765. PubMed ID: 34173167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Models for acute on chronic liver failure development and mortality in a veterans affairs cohort.
    Xiao KY; Hubbard RA; Kaplan DE; Taddei TH; Goldberg DS; Mahmud N
    Hepatol Int; 2020 Jul; 14(4):587-596. PubMed ID: 32519219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validation of prognostic scores to predict short-term mortality in patients with acute-on-chronic liver failure.
    Song DS; Kim TY; Kim DJ; Kim HY; Sinn DH; Yoon EL; Kim CW; Jung YK; Suk KT; Lee SS; Lee CH; Kim TH; Choe WH; Yim HJ; Kim SE; Baik SK; Jang JY; Kim HS; Kim SG; Yang JM; Sohn JH; Choi EH; Cho HC; Jeong SW; Kim MY;
    J Gastroenterol Hepatol; 2018 Apr; 33(4):900-909. PubMed ID: 28921629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of Visceral Fat Obesity, Sarcopenia, and Myosteatosis with Non-Alcoholic Fatty Liver Disease without Obesity.
    Kim HK; Bae SJ; Lee MJ; Kim EH; Park H; Kim HS; Cho YK; Jung CH; Lee WJ; Choe J
    Clin Mol Hepatol; 2023 Oct; 29(4):987-1001. PubMed ID: 37403320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute-on-chronic liver failure: A comparison of three different diagnostic criteria.
    Leão GS; Lunardi FL; Picon RV; Tovo CV; de Mattos AA; de Mattos ÂZ
    Ann Hepatol; 2019; 18(2):373-378. PubMed ID: 31053547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sarcopenia and Myosteatosis Predict Adverse Outcomes After Emergency Laparotomy: A Multi-center Observational Cohort Study.
    Body S; Ligthart MAP; Rahman S; Ward J; May-Miller P; Pucher PH; Curtis NJ; West MA;
    Ann Surg; 2022 Jun; 275(6):1103-1111. PubMed ID: 33914486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.